INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
REPORT OUTLOOK
| Market Size | CAGR | Dominating Region |
|---|---|---|
| reach USD 10.4 billion by 2032 | 11.6% | North America |
| By Type | By Therapeutic Areas |
|---|---|
-Therapeutics
|
|
SCOPE OF THE REPORT
Personalized Psychiatry Market
The personalized psychiatry market, valued at USD 4.6 billion in 2023, is projected to reach USD 10.4 billion by 2032, growing at a CAGR of 11.6% during the forecast period from 2024 to 2032.
An approach to mental health care known as “personalized psychiatry” considers each patient’s particular traits, background, and way of life. Its foundation is the notion that there is no one-size-fits-all strategy for mental health. Personalized psychiatry, on the other hand, is geared toward the unique needs and objectives of each patient.
Using the most recent findings in neurology, psychiatry, and psychotherapy, personalized psychiatry is an evidence-based practice that develops a unique treatment plan for each patient. This entails a thorough evaluation of the person’s biological, lifestyle, and mental health. The evaluation of the patient’s symptoms and current functioning are combined with a review of the patient’s medical, psychological, and social histories. Based on this evaluation, a customized treatment plan that meets the needs of the patient is made.
A combination of medication, psychotherapy, lifestyle modifications, and additional interventions like yoga, meditation, and mindfulness may be included in the individualized treatment plan. The goal of this strategy is to assist the person in enhancing both their general and mental wellbeing.
Research has demonstrated the efficacy of personalized psychiatry as a mental health treatment strategy. It is crucial to remember that this method does not replace conventional therapies like medication and psychotherapy. Rather, it is a supplemental strategy that can support and improve conventional therapies while offering a personalized plan for mental health improvement.
Personalized Psychiatry Market Report Scope
| ATTRIBUTE | DETAILS |
| Market Size Value In 2023 | USD 24.1 Billion |
| Revenue Forecast In 2032 | USD 34.9 Billion |
| Growth Rate CAGR | CAGR of 4.5% from 2024 to 2032 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2024 to 2032 |
| Forecast Year | 2024-2032 |
| Historic Year | 2019 to 2023 |
| By Product |
|
| By End-User |
|
| By Region |
|
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Competitive Landscape | GreyBird Ventures, Sunovion Pharmaceuticals Inc., HMNC Holding GmbH, Arcara Personalized Psychiatry, Starling Minds, Karuna Therapeutics, CBT Plus, AltheaDx, Inc., WayForward, BrightQuest, Peak Mental Wellness |
Market Dynamic
Market Drivers and Expansion Factors
Several factors drive the expansion of the personalized psychiatry market. Increasing mental health issues, a robust economy, higher consumer spending, rising healthcare expenditures, and a growing population contribute significantly. Additionally, the prevalence of chronic illnesses such as diabetes and cancer underscores the need for personalized diagnostic and treatment methods.
Market Challenges
Despite growth prospects, the market faces challenges such as stringent regulatory requirements and public unfamiliarity. However, the increasing availability of smartphones and high-speed internet has facilitated broader access to personalized psychiatry services, integrating them into daily life.
Market Trends
-
Digital Mental Health: The field of digital mental health technology is expanding quickly and employs digital tools to enhance mental health services. Apps and other digital tools that can be used to track patient behaviour, offer feedback, and carry out interventions are part of this technology. Digital mental health technology is assisting in lowering stigma, increasing accessibility to mental health services, and delivering care in a more practical and economical manner.
-
Wearable Technology: One application of wearable technology is the monitoring of mental and physical health. Clinicians can better understand a patient’s health and adjust treatments by using this technology to track vital signs, sleep patterns, and physical activity. Additionally, patients are receiving real-time feedback through wearable technology to assist in managing their mental health.
-
Artificial Intelligence: Clinicians are using artificial intelligence (AI) to aid in the diagnosis and treatment of mental health disorders. AI is capable of analyzing patient data and giving doctors insights that will enable them to make better treatment decisions. AI is also being used to spot behavioral patterns in patients and offer more individualized care.
-
Smartphone Technology: The provision of mental health services is being enhanced through the use of smartphone technology. Apps for smartphones can be used to deliver interventions, give feedback, and keep an eye on patient behavior. Additionally, smartphone technology is making mental health services more accessible and lowering the stigma associated with them.
Competitive Landscape
Key players in the personalized psychiatry market include:
- GreyBird Ventures
- Sunovion Pharmaceuticals Inc.
- HMNC Holding GmbH
- Arcara Personalized Psychiatry
- Starling Minds
- Karuna Therapeutics
- CBT Plus
- AltheaDx, Inc.
- WayForward
- BrightQuest
- Peak Mental Wellness
Recent Developments
-
In March 2024, Geha Mental Health Center, Clalit Health Services, and Genetika+ announced a collaboration to develop personalized depression treatment tools using stem-cell technology, AI, and advanced analytics.
-
In January 2024, Ketabon GmbH reported positive outcomes from a trial comparing SPRAVATO and KET01 for Treatment-Resistant Depression.
-
The personalized psychiatry market is poised for significant growth, driven by technological innovations, increasing mental health awareness, and the shift towards precision medicine in healthcare. As these trends continue, the market is expected to expand further, addressing critical gaps in mental health diagnosis and treatment worldwide.
Regional Insights
North America: Holds a significant revenue share, driven by high prevalence of mental health disorders, well-established healthcare infrastructure, substantial R&D funding, and strong governmental support for personalized treatment approaches.
Asia Pacific: Expected to witness substantial growth, fueled by advancements in genetic diagnostics, growing mental health awareness, increased healthcare funding, rising prevalence of mental illnesses, and public recognition of mental health importance.
Stakeholders for the market
- Healthcare Providers and Psychiatrists
- Patients and Caregivers
- Pharmaceutical Companies
- Medical Device Manufacturers
- Research Institutions and Academia
- Healthcare IT Companies
- Regulatory Authorities and Government Agencies
- Insurance Providers and Payers
- Patient Advocacy Groups and Nonprofit Organizations
- Technology and Data Privacy Experts
Key Market Insights
Products Segment Leading Growth: The products segment dominates the market, driven by advanced diagnostic tools, genetic testing kits, and tailored treatment options that enhance accuracy in diagnosing mental health issues and designing personalized treatment plans.
Rapid Growth in Depression Segment: The depression segment is expanding rapidly due to increased cases, advancements in genetic and biomarker research, and the demand for personalized treatment programs that optimize therapeutic outcomes based on individual genetic profiles.
Segmentation of Personalized Psychiatry Market
Personalized Psychiatry Market- By Type
- Products -Diagnostics
-Therapeutics
- Services
- Software
Personalized Psychiatry Market- By Therapeutic Areas
- Depression
- Anxiety
- Bipolar Disorder
- Schizophrenia
- Addiction
- Others
Personalized Psychiatry Market-By Region
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
FAQ
Personalized psychiatry is an approach to mental health care that customizes treatment plans based on individual factors such as genetic makeup, environmental influences, and lifestyle choices. It aims to enhance treatment effectiveness by tailoring therapies to each patient’s unique needs.
The market is driven by increasing mental health disorders, advancements in genetic and biomarker research, higher healthcare expenditures, rising consumer spending on health, and a growing global population with chronic illnesses like diabetes and cancer.
Traditional psychiatric treatment often follows standardized protocols for diagnosis and treatment. In contrast, personalized psychiatry uses genetic testing, biomarkers, and other personalized data to create tailored treatment plans that better match the patient’s biological and psychological profile.
Personalized psychiatry services typically include advanced diagnostic tools (like genetic testing kits), personalized treatment plans based on individual genetic and environmental factors, and ongoing monitoring and adjustments to treatment as needed.
Therapeutic areas such as depression, anxiety disorders, bipolar disorder, schizophrenia, addiction, and other complex mental health conditions benefit significantly from personalized psychiatry. These conditions often require nuanced treatment approaches that consider individual patient differences.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.